%0 Journal Article
%T Relevance of the Weber effect in contemporary pharmacovigilance of oncology drugs
%A Ankur Arora
%A Divya Vohora
%A Rajinder K Jalali
%J Archive of "Therapeutics and Clinical Risk Management".
%D 2017
%R 10.2147/TCRM.S137144
%X Numerous reporting biases have been known to affect spontaneous reporting databases. The Weber effect, which constitutes a peak in adverse event (AE) reporting of a drug at the end of second year after regulatory approval followed by a continuous decline thereafter, has been considered an important bias for a long time. The existence of this bias in AE reporting of oncology drugs remains an underevaluated area, prompting a targeted examination
%K Weber effect
%K adverse event reporting patterns
%K oncology drugs
%K USFDA
%K FAERS
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602442/